Gynostemma pentaphyllum Ethanolic Extract Protects Against Memory Deficits in an MPTP-Lesioned Mouse Model of Parkinson's Disease Treated with L-DOPA

J Med Food. 2017 Jan;20(1):11-18. doi: 10.1089/jmf.2016.3764. Epub 2016 Dec 22.

Abstract

This study investigated the effects of ethanol extract from Gynostemma pentaphyllum (GP-EX) on memory deficits in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned mouse model of Parkinson's disease (PD) (MPTP-lesioned mice). MPTP (30 mg/kg/day, 5 days)-lesioned mice showed deficits of habit learning memory and spatial memory, which were further aggravated by treatment with L-3,4-dihydroxyphenylalanine (L-DOPA) (25 mg/kg, 21 days). However, treatment with GP-EX (50 mg/kg, 21 days) ameliorated memory deficits in MPTP-lesioned mice treated with L-DOPA (25 mg/kg): GP-EX prevented the decreases in retention latency time in the passive avoidance test and tyrosine hydroxylase-immunopositive cells and dopamine levels in the nigrostriatum. GP-EX also reduced increases in retention transfer latency time of the elevated plus-maze test and expression of N-methyl-D-aspartate (NMDA) receptor and improved decreases in phosphorylation of extracellular signal-regulated kinase (ERK1/2) and cyclic AMP-response element binding protein (CREB) in the hippocampus in the same models. By contrast, L-DOPA treatment (10 mg/kg, 21 days) ameliorated memory deficits in MPTP-lesioned mice, which were further improved by GP-EX treatment. These results suggest that GP-EX ameliorates habit learning memory deficits by activating dopaminergic neurons and spatial memory deficits by modulating NMDA receptor-ERK1/2-CREB system in MPTP-lesioned mice treated with L-DOPA. GP-EX may serve as an adjuvant phytonutrient for memory deficits in PD.

Keywords: Gynostemma pentaphyllum; L-DOPA; MPTP-lesioned mouse; Parkinson's disease; memory deficits.

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / adverse effects
  • Animals
  • Antiparkinson Agents / therapeutic use*
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Disease Models, Animal
  • Dopamine / metabolism
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Gynostemma / chemistry*
  • Humans
  • Levodopa / therapeutic use*
  • Male
  • Memory / drug effects
  • Mice
  • Mice, Inbred C57BL
  • Parkinson Disease / prevention & control*
  • Parkinson Disease / psychology
  • Plant Extracts / administration & dosage*
  • Plant Extracts / isolation & purification
  • Protective Agents / administration & dosage*
  • Protective Agents / isolation & purification
  • Substantia Nigra / drug effects
  • Substantia Nigra / metabolism

Substances

  • Antiparkinson Agents
  • Cyclic AMP Response Element-Binding Protein
  • Plant Extracts
  • Protective Agents
  • Levodopa
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Extracellular Signal-Regulated MAP Kinases
  • Dopamine